ArticleFrontiers in immunology2026

Automated manufacturing of clinical-grade BDCA2 CAR NK cells in a closed system for the treatment of blastic plasmacytoid dendritic cell neoplasm.

Rita Pfeifer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.